Vericel - 48 Year Dividend History | VCEL

Historical dividend payout and yield for Vericel (VCEL) since 1971. The current TTM dividend payout for Vericel (VCEL) as of November 13, 2019 is $0.00. The current dividend yield for Vericel as of November 13, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.856B $0.091B
Vericel Corporation is focused on developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. The company markets two autologous cell therapy products in the United States: Carticel (R) for the treatment of cartilage defects in the knee, and Epicel (R) for the treatment of severe burns. It is also developing MACI (TM) for the treatment of cartilage defects in the knee, and ixmyelocel-T for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy. Vericel Corporation, formerly Aastrom Biosciences, Inc., is based in United States.
Stock Name Country Market Cap PE Ratio